Rheumato (May 2023)

Non-Multisystem Inflammatory Syndrome in Children—Postacute Sequelae of Paediatric COVID-19: Autoimmune or Autoinflammatory? A Systematic Review of the Reported Cases

  • Antoine Fakhry AbdelMassih,
  • Maram Hamed Hanafy,
  • Maryam ElAhmady,
  • Sylvia Kozman,
  • Nourine Diab,
  • Reem Husseiny,
  • Ashrakat Deyab,
  • Aalaa Mady,
  • Alia Yasser,
  • Amira R. AbdelHalim,
  • Aya Mohyeldin,
  • Aya Sayed Serour,
  • Ayat AbdelGadir,
  • Eslam Abdelaziz,
  • Farida ElGhamry,
  • Hana Amr,
  • Karim Milad,
  • Lamya Fouda,
  • Mawada Hesham,
  • Mina Adly Riad,
  • Mohamed Aoun,
  • Rana AbdelTawab,
  • Rana Sayed,
  • Salma ElSenbawy,
  • Sara ElAhmady Abdelkhalek,
  • Nada Gamal,
  • Yasmin Omar

DOI
https://doi.org/10.3390/rheumato3020011
Journal volume & issue
Vol. 3, no. 2
pp. 132 – 168

Abstract

Read online

Three years after its emergence, coronavirus disease 2019 (COVID-19) continues to be a leading cause of worldwide morbidity and mortality. This systematic review comprises relevant case reports that discuss non-multisystem inflammatory syndrome in children (non-MIS-C) and postacute sequalae of COVID-19 (PASC) in the paediatric population, also known as long COVID syndrome. The study aims to highlight the prevalent time interval between COVID-19 and the development of non-MIS-C post-infectious sequalae (PIS). Databases were searched for studies that met our inclusion and exclusion criteria. The final screening revealed an equal sex distribution where the commonest age intervals were school-age and adolescence, with 38% of the patients being older than six years. Interestingly, hospital admission during the course of COVID-19 was not a predictor of the subsequent PASC; forty-nine patients (44.9%) were hospitalized while sixty patients (55.1%) were not hospitalized. Moreover, the most predominant time interval between COVID-19 and the developing PASC was within 14 days from the start of COVID-19 infection (61%). These findings suggest a crucial link between COVID-19 and immune PIS in the paediatric population, especially those older than six years. Accordingly, follow-up and management are encouraged in case of unusual symptoms and signs following COVID-19 infection, regardless of the COVID-19 infection severity.

Keywords